ClinConnect ClinConnect Logo
Search / Trial NCT05819697

Reducing Patient Memory Recall in the Burning Mouth Patient Population

Launched by UNIVERSITY OF PENNSYLVANIA · Apr 5, 2023

Trial Information

Current as of July 28, 2025

Recruiting

Keywords

Burning Mouth Syndrome Oral Pain Burning Mouth Chronic Intraoral Burning Sensation

ClinConnect Summary

This clinical trial is studying a condition called Burning Mouth Syndrome (BMS), which causes ongoing pain and discomfort in the mouth. The goal is to better understand how symptoms change throughout the day by using a smartphone app to collect real-time information from patients. Researchers will also look at saliva samples to find specific markers that might be linked to the symptoms of BMS. This study is a collaboration between Penn Dental Medicine and the Wharton School of Business, aiming to improve how we understand and track this condition.

To participate, you need to be at least 18 years old and have been diagnosed with BMS for at least three months. You should also have access to a smartphone and be willing to provide saliva samples. If you join the study, you will attend two visits where you'll fill out questionnaires and give saliva samples. For 12 weeks, you'll receive prompts on your smartphone to report your symptoms three times a day. This trial is currently recruiting participants, and it offers a chance to contribute to important research that could help those suffering from BMS.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Individuals aged 18 years and older
  • 2. Willing and able to provide informed consent
  • 3. Have been diagnosed with BMS for at least three months by an Oral Medicine or other specialist
  • 4. Willing to submit a saliva sample
  • 5. Have continuous access to a smartphone
  • Exclusion criteria:
  • 1. In the opinion of the investigator, is unable or unlikely to comply fully with the study requirements or procedures for any reason (e.g. cognitive or physical impairment)
  • 2. Prior head and neck radiation and/or chemotherapy
  • 3. Medications that modulate or suppress the inflammatory system

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Eugene Ko, DDS

Principal Investigator

Penn Dental School of Medicine, Center for Clinical and Translational Research

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported